Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAyçiçeği-Dinn, Ayşe
dc.contributor.authorGöral F.
dc.contributor.authorKaramursel S.
dc.contributor.authorYildirim E.A.
dc.contributor.authorHacioglu-Yildirim M.
dc.contributor.authorFregni F.
dc.date.accessioned2020-06-28T22:26:27Z
dc.date.available2020-06-28T22:26:27Z
dc.date.issued2016
dc.identifier.issn0941-9500
dc.identifier.urihttps://doi.org/10.1016/j.npbr.2016.08.003
dc.identifier.urihttps://hdl.handle.net/20.500.12723/2058
dc.identifier.urihttps://www.researchgate.net/publication/308017752_Treatment-resistant_obsessive-compulsive_disorder_Insights_from_an_open_trial_of_transcranial_direct_current_stimulation_tDCS_to_design_a_RCT
dc.description.abstractThe present study collected preliminary data testing the hypothesis that a lengthy transcranial direct current stimulation (tDCS) protocol reduces obsessive-compulsive disorder symptoms and strengthens executive control. Five patients presenting with treatment-resistant obsessive-compulsive disorder (TR-OCD) underwent neurocognitive and clinical testing prior to (baseline assessment) and after completing three weeks of tDCS (post-treatment evaluation). Four TR-OCD patients participated in 15 daily tDCS sessions during the three-week trial. One patient participated in 13 sessions. Scalp electrodes were situated using the standard montage for DLPFC stimulation: anode over left DLPFC (F3) and cathode over right frontopolar region (Fp2). We gained significant insights with this extensive testing: (1) TR-OCD patients demonstrated significant OCD symptom reduction following the course of tDCS; however, gains were not maintained at 1-month follow-up; (2) there were changes in depressive and schizotypal (positive) symptoms following three weeks of tDCS; however, baseline/post-treatment differences did not reach significance; (3) TR-OCD patients significantly lowered their daily ratings of depressive and generalized anxiety symptoms; (4) TR-OCD patients obtained a significant and specific improvement in Trail Making Test-part B (TMT-B) performance; and (5) there was a significant and robust correlation between TMT-B improvement and OCD symptom reduction. Although practice and placebo effects cannot be ruled out, the specific effects found in the study support further testing in a randomized controlled trial. Our results provide data to design further randomized clinical trials as to test whether and how tDCS induces a relevant clinical benefit in OCD. We discuss important design considerations for such a trial. © 2016 Elsevier GmbHen_US
dc.description.abstractTelif hakları gereğince yayın erişime kapalıdır. Yayın yayıncı tarafından erişime açık ise bağlantılar kısmından ulaşılabilmektedir.
dc.description.sponsorshipIstanbul Üniversitesien_US
dc.description.sponsorshipThis work was supported by Scientific Research Projects Coordination Unit of Istanbul University. Project number 47528.en_US
dc.language.isoengen_US
dc.publisherElsevier GmbHen_US
dc.identifier.doi10.1016/j.npbr.2016.08.003en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEfficacyen_US
dc.subjectNeurocognitive testingen_US
dc.subjectTranscranial direct current stimulation (tDCS)en_US
dc.subjectTreatment-resistant obsessive-compulsive disorder (TR-OCD)en_US
dc.titleTreatment-Resistant Obsessive-Compulsive Disorder: Insights From An Open Trial Of Transcranial Direct Current Stimulation (tDCS) To Design a RCTen_US
dc.typearticleen_US
dc.departmentİstanbul 29 Mayıs Üniversitesien_US
dc.department-tempDinn, W.M., Department of Psychology, Istanbul 29 Mayis University, Istanbul, Turkey; Aycicegi-Dinn, Ayse, Department of Psychology, Istanbul 29 Mayis University, Istanbul, Turkey, Department of Psychology, Istanbul University, Istanbul, Turkey; Göral, F., Department of Psychology, Fatih University, Istanbul, Turkey; Karamursel, S., Department of Physiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; Yildirim, E.A., Bakirkoy Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey; Hacioglu-Yildirim, M., Bakirkoy Research and Training Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey; Gansler, D.A., Department of Psychology, Suffolk University, Boston, United States; Doruk, D., Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, United States; Fregni, F., Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, United Statesen_US
dc.authorid0000-0002-5982-8983
dc.institutionauthor. . .en_US
dc.identifier.volume22en_US
dc.identifier.issue3-4en_US
dc.identifier.startpage146en_US
dc.identifier.endpage154en_US
dc.relation.ispartofNeurology Psychiatry and Brain Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster